Fact Check in India: ICMR Doesn’t Include Ivermectin in Treatment Guidelines: Contrary to Internet Claims

Fact Check in India ICMR Doesn’t Include Ivermectin in Treatment Guidelines Contrary to Internet Claims

The Indian government hasn’t included ivermectin in its treatment guidelines, although apparently there are claims on social media of the contrary. In fact, ICMR hasn’t recommended the use of the anti-parasite drug for the treatment of COVID-19. As TrialSite reported, in reality, a state government, Uttar Pradesh (UP), authorized the use of the drug off label following the lead of some hospitals in the region, and around the nation already using the drug off label to treat at least mild early onset COVID-19. On August 6, 2020, a UP government circular actually specified the dosage and use of ivermectin for purposes of both prevention and as a treatment of COVID-19.

India’s Factly reported on this important fact check exercise to ensure correct information circulates the internet. The claim associated the recent UP dosage and usage specifications with ICMR, the nation’s research agency, which is outright misleading. TrialSite has reported that ICMR had put forth an initiative to look into the use of ivermectin targeting COVID-19, but little has occurred since then, at least publicly and formally. That investigation was led by Nivedita Gupt...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee